Katakami, Naoto <br/><br/>
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.  [electronic resource] 

 -  Diabetes therapy : research, treatment and education of diabetes and related disorders  Oct 2017 
 - 999-1013 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1869-6953 
<br/><br/><label>Standard No.: </label>10.1007/s13300-017-0292-1  doi